A Study Comparing The Efficacy And Safety Of Lidocaine 5% Patch With Placebo In Patients With Chronic Axial Low Back Pain

Completed · Phase 2 · Has a placebo group

Conditions studied: Chronic Low Back Pain

In brief

Patients with Chronic Axial Low Back Pain participated in a Phase II clinical trial to assess the efficacy of lidocaine 5% patch compared with placebo.

Key facts

Study ID

NCT00904111

Run by

Endo USA Inc., a Keenova Therapeutics Company

People needed

215

Starts

2004-08-01

Last updated by the study team

2013-12-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Study site — Birmingham, Alabama, United States
• Study site — Phoenix, Arizona, United States
• Study site — Carlsbad, California, United States
• Study site — National City, California, United States
• Study site — Waterbury, Connecticut, United States
• Study site — Washington D.C., District of Columbia, United States
• Study site — Port Orange, Florida, United States
• Study site — Atlanta, Georgia, United States
• Study site — Chicago, Illinois, United States
• Study site — Overland Park, Kansas, United States
• Study site — Pittsfield, Massachusetts, United States
• Study site — Burlington, North Carolina, United States
• Study site — Altoona, Pennsylvania, United States
• Study site — Duncansville, Pennsylvania, United States
• Study site — Philadelphia, Pennsylvania, United States
• Study site — Cordova, Tennessee, United States
• Study site — San Antonio, Texas, United States
• Study site — Virginia Beach, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.